Showing results (101-110 of 225) with videos related to
Sort By:
Pageof 23
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 2, 2018
[Study of the Therapeutic Effect and Neutrophil Lymphocyte Ratio in Breast Cancer Patients Who Received Eribulin]Hitomi Kubota, Keita Adachi, Shuhei Suzuki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Diagnosis of ductal carcinoma in situ with interruption of the anterior border of the mammary gland by ultrasonography-a case report]Kenichi Sakurai, Shigeru Fujisaki, Tetsuyo Maeda, et al.Life (Basel, Switzerland)|September 28, 2021
Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 ReductionShuhei Suzuki, Masahiro Yamamoto, Tomomi Sanomachi, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|October 6, 2024
[Minimally Invasive Aortic Valve Replacement for Aortic Valve Infective Endocarditis Complicated by Septic Arthritis of the Sternoclavicular Joint:Report of a Case]Ryohei Kobayashi, Kenji Aoki, Yuki Takamatsu, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Phyllodes Tumor of the Breast Occurring near Postoperative Fibroadenoma Scar-A Case Report]Kenichi Sakurai, Shuhei Suzuki, Tomohiro Hirano, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[Diagnosis of a Non-Invasive Ductal Carcinoma, Assisted by Long-Term Follow-Up of Spontaneous Nipple Discharge - A Case Report]Tomohiro Hirano, Shuhei Suzuki, Keita Adachi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2014
[CD147 expression in non-invasive and invasive breast carcinoma]Saki Nagashima, Kenichi Sakurai, Shuhei Suzuki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[Role of Pudendal Sensory Nerve in Patients with or without Fecal Incontinence after Low Anterior Resection for Lower Rectal Cancer]Ryouichi Tomita, Kenichi Sakurai, Shigeru Fujisaki, et al.Cancers|July 10, 2019
Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin ReductionShuhei Suzuki, Masahiro Yamamoto, Tomomi Sanomachi, et al.Cancers|October 17, 2019
Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer DrugsTomomi Sanomachi, Shuhei Suzuki, Keita Togashi, et al.Pageof 23